Analysed BIOLINERX LTD-SPONS ADR (BLRX:NASDAQ) News Sources
BioLineRx Announces Initiation of Phase 1/2a Study of GLIX1 for the Treatment of Glioblastoma (GBM)
26-03-2026
yahoo.com
BioLine Rx Ltd (BLRX) Full Year 2025 Earnings Call Highlights: Navigating Challenges and ...
26-03-2026
yahoo.com
BioLine Rx Ltd (BLRX) Q3 2025 Earnings Call Highlights: Strategic Advances Amid Financial ...
29-11-2025
yahoo.com
BioLineRx Reports Third Quarter 2025 Financial Results and Provides Corporate Update
24-11-2025
yahoo.com
What is the current price of BIOLINERX LTD-SPONS ADR (BLRX:NASDAQ)?
The current price of BIOLINERX LTD-SPONS ADR (BLRX:NASDAQ) is $2.24.
BIOLINERX LTD-SPONS ADR (BLRX:NASDAQ) absolute price change since previous trading day?
The absolute price change of BIOLINERX LTD-SPONS ADR (BLRX:NASDAQ) since the previous trading day is $-0.0771.
BIOLINERX LTD-SPONS ADR (BLRX:NASDAQ) percentage price change since previous trading day?
The percentage price change of BIOLINERX LTD-SPONS ADR (BLRX:NASDAQ) since the previous trading day is -3.3274%.
What is the most recent average sentiment score for BIOLINERX LTD-SPONS ADR (BLRX:NASDAQ)?
The most recent average sentiment score for BIOLINERX LTD-SPONS ADR (BLRX:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for BIOLINERX LTD-SPONS ADR (BLRX:NASDAQ)?
The most recent sentiment for BIOLINERX LTD-SPONS ADR (BLRX:NASDAQ) is .
SEC-8K** Filing Available For BIOLINERX LTD-SPONS ADR (BLRX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.